| Bioactivity | Denibulin (MN-029) hydrochloride is an anti-angiogenic agent with anticancer activity. It can cause rapid closure of blood vessels in solid tumors and lead to dose-dependent killing of tumor cells, effectively enhancing the antitumor effects of radiation and cisplatin chemotherapy[1]. |
| CAS | 779356-64-8 |
| Formula | C18H20ClN5O3S |
| Molar Mass | 421.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shi W, et al. Preclinical studies of the novel vascular disrupting agent MN-029. Anticancer Res. 2005 Nov-Dec;25(6B):3899-904. |
Denibulin hydrochloride
CAS: 779356-64-8 F: C18H20ClN5O3S W: 421.90
Denibulin (MN-029) hydrochloride is an anti-angiogenic agent with anticancer activity. It can cause rapid closure of blo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.